Individual response to biologic drugs varies greatly and many factors influence this individual patient response:
- Systemic inflammation
- Other drug therapies
- Pharmacogenetic factors
- Disease phenotype
- Body mass
- Immunogenicity
- Immunomodulators
- Presence of anti-drug antibodies
OptimAbs helps healthcare providers maximize the efficacy of biologic therapy. Use for all of your IBD patients—whenever you need therapeutic guidance.
OptimAbs TDM enables you to:
- Monitor at induction and during maintenance treatment to ensure appropriate therapeutic drug levels
- Manage at loss of response/no response to clarify non-response origin and guide subsequent therapeutic decisions
- Guide therapeutic de-escalation in patients in remission to minimize drug exposure and cost